Sutro Biopharma, Inc. STRO
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Sutro Biopharma, Inc. is a clinical-stage biotechnology company specializing in oncology, headquartered in South San Francisco, California. The company focuses on discovering, developing, and manufacturing next-generation antibody-drug conjugates (ADCs) using its proprietary, integrated cell-free protein synthesis plat…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees133
TickerSTRO
Statistics
Market Cap$471.7M
Revenue (TTM)$102.5M
Net Income-$191.1M
Net Margin-186.5%
EPS$-22.49
P/E-1.29
P/S4.79
P/B-5.65
EV/EBITDA-3.11
ROE144.3%
Dividend Yield—
Price$28.47
Data: Twelve Data · Revenue = mcap / P/S